Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2008 064 784.6 |
96 | EP file number | EAKZ | 20 20 0633.4 |
97 | EP publication number | EPN | 3825306 |
54 | Designation/title | TI | MORPHINANVERBINDUNGEN |
51 | IPC main class | ICM (ICMV) | C07D 221/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07B 59/00 (2006.01), A61K 31/439 (2006.01), A61P 11/14 (2006.01) |
22 | DE application date | DAT | Apr 30, 2008 |
96 | EP application date | EAT | Apr 30, 2008 |
43 | Date of first publication | OT | May 26, 2021 |
| Date of publication of grant | PET | Jun 7, 2023 |
71/73 | Applicant/owner | INH | Sun Pharmaceutical Industries, Inc., Princeton, NJ, US |
72 | Inventor | IN | TUNG, Roger, Lexington, Massachusetts 02420, US |
| Address for service | | Marks & Clerk LLP, 1017 Luxembourg, LU |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 91513007 P May 1, 2007
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 91666207 P May 8, 2007
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 97604407 P Sep 28, 2007
|
| Due date | FT FG | Apr 30, 2026 Annual fee for the 19th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003825306A1 Searchable text:
EP000003825306A1 Original document:
EP000003825306B1 Searchable text:
EP000003825306B1 |
43 | Date of first publication | EVT | May 26, 2021 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2021 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 12, 2025 (Show all update days)(Hide all update days)- Apr 12, 2025
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 07.06.2023: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 07.06.2023: deleted
- Nov 29, 2024
- St.36: changed (technical change)
- May 9, 2024; Apr 25, 2024; Mar 26, 2024; Jul 12, 2023; Jun 20, 2023; Jun 1, 2023; May 11, 2023
- Historical data not available for this/these date(s)
- May 26, 2021
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 11, 2023 |
71/73 | Applicant/owner | INH | Sun Pharmaceutical Industries, Inc., Princeton, NJ, US |
71/73 | Previous applicant/owner | INHF | CoNCERT Pharmaceuticals, Inc., Lexington, MA, US |
| Date of update of the procedure | REGT | Jul 12, 2023 |